Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
LINC01145 is a long intergenic non-coding RNA (lncRNA), part of a class of RNA molecules over 200 nucleotides in length that do not encode proteins and whose functional characterization remains incomplete. Predictions suggest it may be involved in translation through triplet codon–amino acid adaptor activity, though this is not experimentally confirmed. There is no published evidence linking LINC01145 to specific biological pathways, disease processes, or use as a therapeutic target or biomarker. This molecule should not be confused with similarly named lncRNAs (e.g., linc01184), some of which have reported disease associations.
Not applicable
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Long intergenic non-protein coding RNA 1145 (LINC01145).